Aleglitazar: all 22 studies that test it
Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
- A Study of The Effect of Hepatic Impairment on The Pharmacokinetics of AleglitazarCompletedNCT01197911Phase 1Results posted
- A Study of Alegitazar in Patients With Type 2 Diabetes And Chronic Kidney Disease (Alerenal Study)WithdrawnNCT01893242Phase 3
- A Study of Aleglitazar in Monotherapy in Patients With Type 2 Diabetes Mellitus Who Are Drug-Naïve to Anti-Hyperglycemic TherapyCompletedNCT01871428Phase 3
- A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin MonotherapyCompletedNCT01871415Phase 3
- A Study of The Effect of Aleglitazar on Insulin Sensitivity in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With MetforminCompletedNCT01729403Phase 2
- A Study on The Potential of Aleglitazar to Reduce Cardiovascular Risk in Patients With Stable Cardiovascular Disease and Glucose AbnormalitiesCompletedNCT01715818Phase 3
- A Pharmacokinetic Study of Aleglitazar in Healthy Chinese VolunteersCompletedNCT01711775Phase 1
- A Pharmacokinetics Study of Aleglitazar in Combination With Digoxin in Healthy VolunteersCompletedNCT01701739Phase 1
- A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Sulfonylurea Alone or Sulfonylurea Plus Metformin TherapyCompletedNCT01691989Phase 3
- A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin AloneCompletedNCT01691846Phase 3
- A Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus Who Have Not Previously Received Anti-Hyperglycemic TherapyCompletedNCT01691755Phase 3
- A Study to Evaluate the Effect of Aleglitazar on Cardiac Energetics and Function in Patients With Type 2 Diabetes Mellitus and no History of Coronary Artery DiseaseCompletedNCT01680978Phase 2
- A Study to Investigate the Effects of Rifampicin on the Pharmacokinetics of Aleglitazar in Healthy VolunteersCompletedNCT01679639Phase 1
- A Study of Aleglitazar in Combination With Oral Contraceptive Healthy VolunteersCompletedNCT01615354Phase 1
- A Pharmacodynamic/Pharmacokinetic Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus on Treatment With LisinoprilCompletedNCT01398267Phase 1
- A Study of Aleglitazar in Combination With Ibuprofen in Healthy VolunteersCompletedNCT01188317Phase 1
- A Study of Aleglitazar in Combination With Aspirin in Healthy VolunteersCompletedNCT01188304Phase 1
- A Study of Aleglitazar in Type 2 Diabetes Patients With Moderate Renal ImpairmentCompletedNCT01043029Phase 2
- A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes MellitusCompletedNCT01042769Phase 3
- A Comparative Study of Aleglitazar and Actos in Patients With Type 2 Diabetes Mellitus and New York Heart Association (NYHA) Class II Heart Failure.CompletedNCT00461058Phase 2
- A Comparison of the Effects of Aleglitazar and Actos on Renal Function on Patients With Type 2 Diabetes.CompletedNCT00461006Phase 2
- A Study of Aleglitazar in Patients With Type 2 DiabetesCompletedNCT00388518Phase 2